Clinical Efficacy of Xiao'er Dingchuan Oral Liquid Combined with Inhaled Budesonide in the Treatment of Bronchopneumonia in Children and its Effect on Inflammatory Level
Objective To observe the clinical efficacy of Xiao'er Dingchuan oral liquid combined with inhaled budesonide in the treatment of bronchopneumonia in children and its effect on inflammatory level.Methods A total of 64 children with bronchopneumonia diagnosed and treated in our hospital from August 2022 to August 2023 were selected as the research objects.They were divided into control group and observation group by random number table method,with 32 children in each group.The control group was treated with inhaled budesonide,and the observation group was treated with Xiao'er Dingchuan oral liquid on the basis of the control group.The clinical efficacy,inflammatory factors[white blood cell count(WBC),C-reactive protein(CRP),neutrophils]levels,clinical symptoms(wheezing,fever,cough,pulmonary rales)remission time,respiratory symptoms(cough,sputum,wheezing)scores,and incidence of adverse reactions were compared between the two groups.Results The total effective rate of treatment in the observation group was 96.88%,which was higher than 81.25%in the control group(P＜0.05).After treatment,the levels of WBC,CRP and neutrophils in the two groups were lower than those before treatment,and those in the observation group were lower than those in the control group(P＜0.05).The remission time of wheezing,fever,cough and pulmonary rales in the observation group were shorter than those in the control group(P＜0.05).After treatment,the scores of cough,expectoration and wheezing in the two groups were lower than those before treatment,and those in the observation group were lower than those in the control group(P＜0.05).There was no significant difference in the incidence of adverse reactions between the observation group and the control group(P＞0.05).Conclusion Xiao'er Dingchuan oral liquid combined with inhaled budesonide can improve the therapeutic effect of bronchopneumonia in children,reduce its clinical symptoms,reduce the level of inflammatory factors,and will not increase the incidence of adverse reactions.It is an effective treatment plan.
国家科技期刊平台
NSTL
万方数据
